# Baudouin Hue

> Baudouin Hue is a seed investor at Karista (Paris) backing Medical and Health Care. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Karista](https://shizune.co/investors/profile/karista)
- Location: Paris, France
- Total investments: 5
- Last investment: Sep 2024
- Lead investor: 20%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/baudouin-hue-ba1a5323

Baudouin Hue is a seed investor at Karista in Paris focused on Medical and Health Care. Baudouin Hue - Partner @ Karista

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 60% |
| Health Care | 3 | 60% |
| Medical Device | 3 | 60% |
| Biotechnology | 2 | 40% |
| mHealth | 1 | 20% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 40% |
| Series A | 2 | 40% |
| Series B | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 3 | 60% |
| Belgium | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Brightflow | Brightflow operates as a medical device startup. | $18.2M | Series A | Sep 10, 2024 |  |
| Implicity | Implicity is a developer of a Saas-based remote monitoring platform designed to provide smart monitoring of connected cardiac prostheses. The company's platform sorts and summarizes data of patients with connected pacemakers and defibrillators with the help of an artificial intelligence module and determines the criticality of each alerttaking into account the medical context of the patient, enabling cardiologists and healthcare professionals to automate the remote monitoring of their patients and get patients' telepulse on a single platform. | $23M | Series A | Apr 27, 2022 |  |
| moveUP | moveUP develops and commercialise digital therapeutics solutions. Its closed loop system enables high compliance, better outcome and satisfaction. It uses continuously collected data to directly personalise the treatment of the patient. Its first therapy treats orthopaedic patients undergoing a joint surgery. It has CE medical device & ISO13485 certification. | $4.5M | Seed | May 24, 2021 |  |
| Implicity | Implicity is a developer of a Saas-based remote monitoring platform designed to provide smart monitoring of connected cardiac prostheses. The company's platform sorts and summarizes data of patients with connected pacemakers and defibrillators with the help of an artificial intelligence module and determines the criticality of each alerttaking into account the medical context of the patient, enabling cardiologists and healthcare professionals to automate the remote monitoring of their patients and get patients' telepulse on a single platform. | $4.4M | Seed | Mar 14, 2019 |  |
| Pherecydes Pharma | Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to itsouter membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria. | $9.5M | Series B | Jan 16, 2018 |  |

5 of 5 investments shown.

## Co-investors
- [BNP Paribas Développement](https://shizune.co/investors/profile/bnp-paribas-developpement) — VC Fund, 2 deals together
- [GO CAPITAL](https://shizune.co/investors/profile/ouest-ventures) — VC Fund, 2 deals together
- [Serena](https://shizune.co/investors/profile/serena-capital) — VC Fund, 2 deals together
- [XAnge](https://shizune.co/investors/profile/xange-private-equity) — VC Fund, 2 deals together
- [Ace Capital Partners](https://shizune.co/investors/profile/ace-capital-partners) — VC Fund, 1 deal together
- [Auriga Partners](https://shizune.co/investors/profile/auriga-partners) — VC Fund, 1 deal together

## About Karista

VC Fund · Paris, France

Karista is an early-stage venture capital firm created in 2001. We funded 90+ companies over the past two decades and support tomorrow’s game changers in the field of Health, Digital, Tech, and NewSpace. We have always worked to provide more than cash and partnered with entrepreneurs whom we share a common vision with.

5 contacts available at Karista.

| Name | Title | Profile |
| --- | --- | --- |
| Agathe Testu | Secretary General - RCCI | https://shizune.co/investors/profile/agathe-testu |
| Baudouin Hue | Partner | https://shizune.co/investors/profile/baudouin-hue |
| Benjamin Zerbib | Investment Director | https://shizune.co/investors/profile/benjamin-zerbib |
| Catherine Boule | Managing Partner | https://shizune.co/investors/profile/catherine-boule |
| Elodie Feraille | Management Assistant | https://shizune.co/investors/profile/elodie-feraille |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Baudouin Hue invest in?

Baudouin Hue invests primarily in Medical, Health Care and Medical Device startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Baudouin Hue last invest?

The most recent investment recorded for Baudouin Hue closed in Sep 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co